Rockwell Automation, Inc. Q3 FY2025 earnings call

Management Statement and Operational Highlights

• Initial Comments: Rockwell had a good quarter with return to year-over-year sales growth. Made progress on segment margin goals, achieving $250 million in year-over-year productivity a quarter earlier than anticipated. Plan to invest over $2 billion in plants, digital infrastructure, and talent over 5 years.
• Third Quarter Results: Reported sales up 5%, organic sales up over 4% year-over-year. Annual recurring revenue grew 7% but was offset by weakness in recurring services. Intelligent Devices had strategic wins in fresh food and soybean processing. Software & Control had strong growth. Lifecycle Services saw project delays but book-to-bill above 1.0.
• Industry Performance: Discrete sales up 10% (automotive, e-commerce/warehouse automation). Hybrid sales up high single digits (food/beverage, life sciences). Process Industries sales down low single digits due to weak demand, but had wins in renewables and oil/gas.
• Fiscal 2025 Outlook: Top line outlook unchanged with slight increase due to tariffs and currency. Reported and organic sales growth in 1%-2% range. Annual recurring revenue to grow high single digits. Segment margin ~20%, adjusted EPS outlook $10 midpoint, free cash flow conversion expected to be 100%

Segment Performance

• Intelligent Devices: Organic sales up 1% year-over-year. Double-digit growth in products offset the decline in the longer-cycle configure-to-order business. Secured wins like Freshpet (pet food manufacturer expanding capacity) and Incobrasa Industries (Brazilian soybean processing company). Clearpath sales up double digits but affected by automotive CapEx delays.
• Software & Control: Organic sales grew 22% year-over-year, driven by strong hardware growth. Logic sales up over 30% year-over-year and low double digits sequentially. SaaS business grew 10% year-over-year with wins like Beam Therapeutics.
• Lifecycle Services: Organic sales declined 6% year-over-year, in line with expectations due to project delays. Book-to-bill in this segment was 1.06, above 1.0 across contributing businesses

Guidance

• Sales: Narrowed sales guidance range, midpoint of reported sales guidance is negative 0.5% year-over-year decline, reflecting tariff-based price increases and currency.
• EPS: Adjusted EPS guidance range $9.80-$10.20, midpoint $10. Full year segment margin ~20%, free cash flow conversion 100%.
• Timing: Modest shift in sales calendarization from Q4 to Q3 due to trade uncertainty, with some customers pulling forward orders from Q4 to Q3

Risks

• Trade Uncertainty: U.S. trade policy with some countries remains uncertain, geopolitical risk elevated.
• Tariffs: Impact on pricing and customer spending decisions, with tariff-related price increases affecting the top line.
• Incentive Comp: Increased incentive expense in Q4 due to outperformance and higher guidance, with full year compensation expense expected to be about $230 million

Question and Answer

Q: Talk about CapEx stuff, why now?

A: Solidly on offense, investing to expand margins. Includes plants, talent, digital infrastructure. ROI-based with double-digit hurdle rate.

Q: Current environment supportive of bookings?

A: Projects delayed but not canceled. Expect higher intake of orders related to new U.S. capacity in fiscal '25 and '26.

Q: Margin potential in Intelligent Devices?

A: Focus on direct material cost reduction, pricing on long tail SKUs, project recovery, and Clearpath profitability.

Q: Pull forwards vs project delays?

A: Pull forwards in product area, delays in configure-to-order and lifecycle services. Balanced view across verticals.

Q: Pricing outlook and U.S. investments?

A: Price realization expected to be 2%+ full year. U.S. investments to lead to larger orders related to capacity next year